Literature DB >> 10515593

HDL is the major source of vitamin E for type II pneumocytes.

I Kolleck1, M Schlame, H Fechner, A C Looman, H Wissel, B Rüstow.   

Abstract

The alveolar surfactant is a prime target of reactive oxygen species present in air. Alveolar surfactant is supplemented with vitamin E during its assembly in type II pneumocytes. However, it is unknown which of the lipoproteins supply type II pneumocytes with vitamin E. The measurement of the uptake kinetics indicates that HDL might be the primary source of the vitamin E uptake by type II pneumocytes. Vitamin E depletion of rats caused an increase of vitamin E uptake by isolated type II pneumocytes from HDL but not from LDL or VLDL. We demonstrated that type II pneumocytes express the scavenger receptor class B type 1 (SR-B1), an HDL-specific receptor. Vitamin E depletion caused an increased expression of SR-B1 by a post-transcriptional mechanism. The increased vitamin E uptake from HDL and the increased expression of the SR-B1 were reversed by refeeding the vitamin. We propose that HDL is the primary source of vitamin E for type II pneumocytes. The rate of uptake of vitamin E by this cell type might be regulated by the expression of SR-B1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515593     DOI: 10.1016/s0891-5849(99)00139-2

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  17 in total

1.  Revisiting "Good" and "Bad" Cholesterol. The Battle over Flow through Arteries Now Shifts to Flow through Airways.

Authors:  Michael B Fessler
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 21.405

2.  Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense.

Authors:  Kristin A Gabor; Michael B Fessler
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 3.  Complexity of vitamin E metabolism.

Authors:  Lisa Schmölz; Marc Birringer; Stefan Lorkowski; Maria Wallert
Journal:  World J Biol Chem       Date:  2016-02-26

Review 4.  A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease.

Authors:  Michael B Fessler
Journal:  Ann Am Thorac Soc       Date:  2017-11

5.  Emerging roles for cholesterol and lipoproteins in lung disease.

Authors:  Kymberly M Gowdy; Michael B Fessler
Journal:  Pulm Pharmacol Ther       Date:  2012-06-15       Impact factor: 3.410

6.  Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice.

Authors:  H E Miettinen; H Rayburn; M Krieger
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

7.  Tissue distribution of α- and γ-tocotrienol and γ-tocopherol in rats and interference with their accumulation by α-tocopherol.

Authors:  Tomono Uchida; Chisato Abe; Saki Nomura; Tomio Ichikawa; Saiko Ikeda
Journal:  Lipids       Date:  2011-11-01       Impact factor: 1.880

Review 8.  Surfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung Disease.

Authors:  Michael B Fessler; Ross S Summer
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

9.  Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte.

Authors:  Emmanuelle Reboul; Alexis Klein; Florence Bietrix; Béatrice Gleize; Christiane Malezet-Desmoulins; Martina Schneider; Alain Margotat; Laurent Lagrost; Xavier Collet; Patrick Borel
Journal:  J Biol Chem       Date:  2005-12-27       Impact factor: 5.157

10.  Oxidized lipoproteins inhibit surfactant phosphatidylcholine synthesis via calpain-mediated cleavage of CTP:phosphocholine cytidylyltransferase.

Authors:  Jiming Zhou; Alan J Ryan; Jheem Medh; Rama K Mallampalli
Journal:  J Biol Chem       Date:  2003-07-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.